Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kennedy PhRMA-Friendly Agenda Includes Wariness Of Waxman/Hatch Reform

Executive Summary

Waxman/Hatch reform should not be undertaken without setting clear boundaries, Sen. Kennedy (D-Mass.) told the Pharmaceutical Research & Manufacturers of America annual meeting in Naples, Fla., March 31.

You may also be interested in...



Senate Transition Puts Kennedy Atop Health: Rx Marketing In Spotlight?

The return of Sen. Kennedy (D-Mass.) to the chairmanship of the Senate Health Committee could open a pipeline for the grand jury investigations of pharmaceutical marketing to feed into the Washington political debate.

Senate Transition Puts Kennedy Atop Health: Rx Marketing In Spotlight?

The return of Sen. Kennedy (D-Mass.) to the chairmanship of the Senate Health Committee could open a pipeline for the grand jury investigations of pharmaceutical marketing to feed into the Washington political debate.

PBM Rules Are Pivotal Point Of Medicare Rx Debate, Breaux Tells PhRMA

The structure of competition among PBMs is a key point for industry to weigh in on during the Medicare drug benefit debate, Sen. Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting March 31 in Naples, Fla.

UsernamePublicRestriction

Register

LL1134561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel